Royal Canin Unveils Therapeutic Nutrition Innovations at VMX 2026
Event summary
- Royal Canin introduced GLYCOADVANCED™, a feline diet for overweight diabetic cats, at VMX 2026.
- The brand launched home care kits for dermatology, gastrointestinal, and urinary conditions.
- Royal Canin previewed Veterinary Fresh Nutrition, a new therapeutic offering for cats and dogs.
- VMX 2026 is the world's largest veterinary expo, held in January 2026.
The big picture
Royal Canin's innovations at VMX 2026 underscore the growing emphasis on therapeutic nutrition in the pet care industry. As a subsidiary of Mars, Incorporated, Royal Canin leverages its parent company's resources to push the boundaries of pet health nutrition. The introduction of GLYCOADVANCED™ and Veterinary Fresh Nutrition highlights the strategic shift towards science-based, precision nutrition tailored to specific pet health conditions. This move aligns with broader industry trends towards personalized pet care and the increasing demand for veterinary-grade nutritional solutions.
What we're watching
- Market Penetration
- How Royal Canin's new therapeutic offerings will affect its market share in the pet nutrition sector.
- Competitive Dynamics
- Whether Royal Canin can sustain its leadership position against competitors with similar innovations.
- Regulatory Compliance
- The pace at which regulatory approvals for new therapeutic diets will impact Royal Canin's rollout timeline.
Related topics